These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 1282865)

  • 21. [Treatment of multiple sclerosis with interferons].
    Nogales-Gaete J; Arriagada C
    Rev Med Chil; 1996 May; 124(5):597-604. PubMed ID: 9035514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of multiple sclerosis in children and adolescents.
    Tenembaum SN
    Clin Neurol Neurosurg; 2010 Sep; 112(7):633-40. PubMed ID: 20471159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multiple sclerosis: update on current therapies].
    Sato T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1505-7. PubMed ID: 8752446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Escalating immunotherapy of multiple sclerosis--new aspects and practical application.
    Rieckmann P; Toyka KV; Bassetti C; Beer K; Beer S; Buettner U; Chofflon M; Götschi-Fuchs M; Hess K; Kappos L; Kesselring J; Goebels N; Ludin HP; Mattle H; Schluep M; Vaney C; Baumhackl U; Berger T; Deisenhammer F; Fazekas F; Freimüller M; Kollegger H; Kristoferitsch W; Lassmann H; Markut H; Strasser-Fuchs S; Vass K; Altenkirch H; Bamborschke S; Baum K; Benecke R; Brück W; Dommasch D; Elias WG; Gass A; Gehlen W; Haas J; Haferkamp G; Hanefeld F; Hartung HP; Heesen C; Heidenreich F; Heitmann R; Hemmer B; Hense T; Hohlfeld R; Janzen RW; Japp G; Jung S; Jügelt E; Koehler J; Kölmel W; König N; Lowitzsch K; Manegold U; Melms A; Mertin J; Oschmann P; Petereit HF; Pette M; Pöhlau D; Pohl D; Poser S; Sailer M; Schmidt S; Schock G; Schulz M; Schwarz S; Seidel D; Sommer N; Stangel M; Stark E; Steinbrecher A; Tumani H; Voltz R; Weber F; Weinrich W; Weissert R; Wiendl H; Wiethölter H; Wildemann U; Zettl UK; Zipp F; Zschenderlein R; Izquierdo G; Kirjazovas A; Packauskas L; Miller D; Koncan Vracko B; Millers A; Orologas A; Panellus M; Sindic CJ; Bratic M; Svraka A; Vella NR; Stelmasiak Z; Selmaj K; Bartosik-Psujik H; Mitosek-Szewczyk K; Belniak E; Mochecka A; Bayas A; Chan A; Flachenecker P; Gold R; Kallmann B; Leussink V; Mäurer M; Ruprecht K; Stoll G; Weilbach FX;
    J Neurol; 2004 Nov; 251(11):1329-39. PubMed ID: 15592728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta interferons as immunotherapy in multiple sclerosis: a new outlook on a classic drug during the COVID-19 pandemic.
    Dumitrescu L; Papathanasiou A; Coclitu C; Constantinescu CS; Popescu BO; Tanasescu R
    QJM; 2021 Dec; 114(10):691-697. PubMed ID: 33486513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-beta-1b: a review of its use in relapsing-remitting and secondary progressive multiple sclerosis.
    McCormack PL; Scott LJ
    CNS Drugs; 2004; 18(8):521-46. PubMed ID: 15182221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunotherapy of multiple sclerosis: the use of magnetic resonance imaging in the evaluation of clinical trials].
    Ozawa K; Saida T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1501-3. PubMed ID: 8752444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of interferon-beta as a therapy for multiple sclerosis.
    Markowitz C
    Expert Opin Emerg Drugs; 2004 Nov; 9(2):363-74. PubMed ID: 15571491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple sclerosis: interferon beta for some serious forms.
    Prescrire Int; 2007 Dec; 16(92):252-7. PubMed ID: 18092425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologic effects of interferons: relevance to multiple sclerosis.
    Rudick RA; Ransohoff RM
    Mult Scler; 1995; 1 Suppl 1():S12-6. PubMed ID: 9345391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple sclerosis therapy. A practical guide.
    van Oosten BW; Truyen L; Barkhof F; Polman CH
    Drugs; 1995 Feb; 49(2):200-12. PubMed ID: 7729328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial.
    Massacesi L; Tramacere I; Amoroso S; Battaglia MA; Benedetti MD; Filippini G; La Mantia L; Repice A; Solari A; Tedeschi G; Milanese C
    PLoS One; 2014; 9(11):e113371. PubMed ID: 25402490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.
    Lancet; 1998 Nov; 352(9139):1491-7. PubMed ID: 9820296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The comparative anti-herpes simplex virus effects of human interferons.
    Taylor JL; Little SD; O'Brien WJ
    J Interferon Cytokine Res; 1998 Mar; 18(3):159-65. PubMed ID: 9555977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.
    Goodkin DE
    West J Med; 1994 Sep; 161(3):292-8. PubMed ID: 7975569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of interferons in the therapy of melanoma.
    Kirkwood JM; Ernstoff MS
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):180S-184S. PubMed ID: 1701805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Endogenous biological retranslation in current clinical and biological studies].
    Cheknev SB
    Vestn Ross Akad Med Nauk; 2003; (4):28-34. PubMed ID: 12741357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advancing treatment with interferon beta-1b (Betaferon/Betaseron) in the next decade--thinking beyond the standard dose.
    Cook SD
    J Neurol; 2003 Dec; 250 Suppl 4():IV15-20. PubMed ID: 14712397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current status of interferon beta-1b in multiple sclerosis therapy].
    Hartung HP
    Med Klin (Munich); 2001 Sep; 96 Suppl 1():11-6. PubMed ID: 11603110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.